N-acetylcysteine plus usual care for severe alcoholic hepatitis
Treatments studied
Part of Digestive system clinical trials.
This study tests whether adding N-acetylcysteine to standard treatment helps people with severe alcoholic hepatitis. It may improve liver outcomes, especially for those with a high Maddrey score.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old, and you can sign informed consent
- You have acute alcoholic hepatitis diagnosed by standard criteria or a compatible liver biopsy
- Your Maddrey score is 32 or higher
- You do not have jaundice from another cause (like viral hepatitis, HIV, or blocked bile ducts)
- You can take N-acetylcysteine and corticosteroids without allergy or intolerance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving corticosteroids for a longer time, or adding a medicine called N-acetylcysteine, can help people with severe alcoholic hepatitis. It is for patients who have been drinking heavily and recently developed jaundice.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
This trial tests a new medicine called MRG-001 for people with severe alcoholic hepatitis, a liver condition caused by heavy drinking. The study aims to see if the drug can help improve liver function and reduce symptoms.
This trial tests an experimental drug for people with severe alcoholic hepatitis that did not improve with steroids. Participants should have a moderate level of organ failure, but not require a breathing tube or kidney dialysis.
This trial compares two treatments for alcoholic hepatitis: a medicine called mycophenolate mofetil versus the standard steroid treatment. The goal is to see which one works better and has fewer side effects for patients with this liver condition.
This trial tests whether the drug N-acetylcysteine (NAC) can help people with sudden liver failure that is not caused by acetaminophen (like Tylenol). If you qualify, you may receive NAC, which might help your liver recover.
Hear when a new Alcoholic Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.